The diagnosis and treatment of neurological ailments always remain an utmost challenge for
research fraternity due to the presence of BBB. The intranasal route appeared as an …

The sustained and/or targeted delivery of hydrophilic drugs is an important field within drug
delivery, presenting unique challenges when compared to that of hydrophobic drugs. Yet …

Parkinson's disease (PD) is the second most common progressive neurodegenerative
disease that promotes neuronal cell death. The primary treatment strategy for Parkinson's …

Purpose: Rivastigmine hydrogen tartrate (RHT) is commonly used for the treatment of mild to
moderate Alzheimer's disease (AD). The aim of this work was to formulate in-situ pluronic F …

Rasagiline mesylate (RM) is a monoamine oxidase inhibitor that is commonly used to
alleviate the symptoms of Parkinson's disease. However, it suffers from low oral …

Parkinson's disease (PD) affects around ten million people worldwide and is considered the
second most prevalent neurodegenerative disease after Alzheimer's disease. In addition …

In this study, we developed a well-printable biomaterial ink for 3D printing of shape-
maintaining hydrogel scaffolds. The hydrogel base comprised tyramine-modified hyaluronic …

The aim of the present research was to investigate the feasibility of developing polylactide–
polycaprolactone–polyethylene glycol–polycaprolactone–polylactide (PLA–PCL–PEG–PCL …

Purpose: The objective of the research undertaken was to develop the Riluzole (RIZ)
nanoparticles drug delivery system using Transferrin (Tf) as a ligand in the brain. Method …

Central nervous system (CNS) diseases are one of the major health problems. However,
blood-brain barrier (BBB) makes traditional oral and intravenous delivery of CNS drugs …